Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for ouabain (compound)


PubChem
Name: Ouabain
PubChem Compound ID: 12420
Description: A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE.
Molecular formula: C29H44O12
Molecular weight: 584.652 g/mol
Synonyms:
630-60-4; Uabanin; Quabain; Ouabain; Oubain; Ouabaine; BRN 0101712; 36-06-6; Kombetin; SDCCGMLS-0066608.P001.
show more »
DrugBank
Identification
Name: Ouabain
Name (isomeric): DB01092
Drug Type: small molecule
Description: A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE.
Synonyms:
Ouabain, Octahydrate; Strophanthin-G; Strophanthin G; Ouabaine; Ouabagenin L-Rhamnoside; Ouabain Octahydrate; G-Strophanthin
Brand: Gratibain, Acocantherin, Strodival, Uabaina, Rectobaina, Gratus Strophanthin, Purostrophan, Solufantina, Strophosan, Strophoperm, G-Strophicor, Astrobain, Strophalen, Kombetin, Uabanin
Category: Cardiotonic Agents, Enzyme Inhibitors
CAS number: 630-60-4
Pharmacology
Indication: For the treatment of atrial fibrillation and flutter and heart failure
Pharmacology: Ouabain, a cardiac glycoside similar to digitoxin, is used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation.
Mechanism of Action:
Ouabain inhibits the Na-K-ATPase membrane pump, resulting in an increase in intracellular sodium and calcium concentrations. Increased intracellular concentrations of calcium may promote activation of contractile proteins (e.g., actin, myosin). Ouabain also acts on the electrical activity of the heart, increasing the slope of phase 4 depolarization...
show more »
Protein binding: 60%
Affected organisms: Humans and other mammals

Targets


Enzymes


Transporters